The role of a clinically important mutation in the fold and RNA-binding properties of KH motifs

RNA

Volumn 9, Issue 3, 2003, Pages 293-298

  Ramos, Andres ^a   Hollingworth, David ^a   Pastore, Annalisa ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

FMR1 fragile X; KH modules; Nova; RNA binding; Structure

Indexed keywords

ASPARAGINE;

AMINO TERMINAL SEQUENCE; ARTICLE; FRAGILE X SYNDROME; GENE DISRUPTION; GENE MUTATION; GENETIC CONSERVATION; HYDROPHOBICITY; MOLECULAR RECOGNITION; MUTANT; PRIORITY JOURNAL; PROTEIN MOTIF; RNA BINDING; RNA CONFORMATION; RNA ISOLATION; RNA STABILITY;

AMINO ACID MOTIFS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; PROTEIN FOLDING; RNA; RNA-BINDING PROTEINS;

EID: 0037371441     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: 10.1261/rna.2168503     Document Type: Article

References (33)

1. Adinolfi, S., Bagni, C., Musco, G., Gibson, T., Mazzarella, L., and Pastore, A. 1999. Dissecting FMR1, the protein responsible for fragile X syndrome, in its structural and functional domains. RNA 5: 1248-1258.
2. Baber, J.L., Libutti, D., Levens, D., and Tjandra, N. 1999. High precision solution structure of the C-terminal KH domain of heterogeneous nuclear ribonucleoprotein K, a c-myc transcription factor. J. Mol. Biol. 289: 949-962.
3. Bartels, C., Xia, T.H., Billeter, M., Gunter, P., and Wuthrich, K. 1995. The program XEASY for computer-supported NMR spectral-analysis of biological macromolecules. J. Biomol. NMR 6: 1-10.
4. 15N)Ile proteins. Biochemistry 41: 6850-6859.
5. Braddock, D.T., Baber, J.L., Levens, D., and Clore, M. 2002a. Molecular basis of sequence-specific single-stranded DNA recognition by KH domains: Solution structure of a complex between hnRNPK KH3 and single-stranded DNA. EMBO J. 13: 3476-3485.
6. Braddock, D.T., Louis, J.M., Baber, J.L., Levens, D., and Clore, G.M. 2002b. Structure and dynamics of KH domains from FBP bound to single stranded DNA. Nature 415: 1051-1056.
7. Brown, V., Small, K., Lakkis, L., Feng, Y., Gunter, C., Wilkinson, K.D., and Warren, S.T. 1998. Purified recombinant FMRP exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J. Biol. Chem. 273: 15521-15527.
8. De Boulle, K., Ververk, A.J.M.H., Reyniers, E., Vits, L., Hendrickx, J., Van Roy, B., VanDenBos, F., de Graaff, E., Oostra, B.A., and Willems, P.J.A. 1993. Point mutation in the Fmr1 gene associated with fragile X mental retardation. Nat. Genet. 3: 31-35.
9. Delaglio, P., Grzesiek, S., Vuister, G.V., Zhu, G., Pfeifer, J., and Bax, A. 1995. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6: 277-293.
10. Feng, Y., Absher, D., Eberhart, D.E., Brown, V., Malter, H.E., and Warren, S.T. 1997. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell 1: 109-118.
11. Gibson, T.J., Thompson, J.D., and Heringa, J. 1993. The KH domain occurs in a diverse set of RNA-binding proteins that include the antiterminator NusA and is probably involved in binding to nucleic acid. FEBS Lett. 324: 361-366.
12. Grzesiek, S. and Bax, A. 1992a. An efficient experiment for sequential backbone assignment of medium-sized isotopically enriched proteins. J. Magn. Res. 99: 201-207.
13. - 1992b. Correlating backbone amide and side chain resonances in larger proteins by multiple relayed triple resonance NMR. J. Am. Chem. Soc. 114: 6291-6293.
14. Holm, L. and Sander, C. 1993. Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233: 123-138.
15. Kabsch, W. and Sander, C. 1983. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22: 2577-2637.
16. Kaufmann, W.E. 2002. Neurobiology of Fragile X syndrome: From molecular genetics to neurobehavioral phenotype. Microsc. Res. Tech. 57: 131-134.
17. Kay, L.E., Nicholson, L.K., Delaglio, F., Bax, A., and Torchia, D.A. 1992. Pulse sequences for removal of the effects of cross correlation between dipolar and chemical shift anisotropy relaxation mechanisms on the measureament of heteronuclear T1 and T2 values in proteins. J. Mag. Res. 97: 359-375.
18. Laggerbauer, B., Ostareck, D., Keidel, E.M., Ostareck-Lederer, A., and Fischer, U. 2001. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10: 329-338.
19. Lewis, H.A., Chen, H., Edo, C., Buckanovich, R.J., Yang, Y.Y., Musunuru, K., Zhong, R., Darnell, R.B., and Burley, S.K. 1999. Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains. Struct. Fold. Des. 7: 191-203.
20. Lewis, H.A., Musunuru, K., Jensen, K.B., Edo, C., Chen, H., Darnell, R.B., and Burley, S.K. 2000. Sequence-specific RNA binding by a Nova KH domain: Implications for paraneoplastic disease and the fragile X syndrome. Cell 100: 323-332.
21. Liu, Z., Luyten, I., Bottomley, M.J., Messias, A.C., Houngniou-Molango, S., Sprangers, R., Zanier, K., Kramer, A., and Sattler, M. 2001. Structural basis for recognition of the intron branch site RNA by splicing factor 1. Science 294: 1098-1102.
22. 15N Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: Application to interleukin 1 β. Biochemistry 28: 6150-6156.
23. Musco, G., Stier, G., Joseph, C., Castiglione Morelli, M.A., Nilges, M., Gibson, T.J., and Pastore, A. 1996. Three-dimensional structure and stability of the KH domain: Molecular insights into the fragile X syndrome. Cell 85: 237-245.
24. Musco, G., Kharrat, A., Stier, G., Fraternali, F., Gibson, T.J., Nilges, M., and Pastore, A. 1997. The solution structure of the first KH domain of Fmr1, the protein responsible for the fragile X syndrome. Nat. Struct. Biol. 4: 712-716.
25. Piotto, M., Saudek, V., and Sklenar, V. 1992. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2: 661-665.
26. Ramos, A., Hollingworth, D., Major, S.A., Adinolfi, S., Kelly, G., Muskett, F.W., and Pastore, A. 2002. The role of dimerisation in KH/RNA complexes: The example of Nova KH3. Biochemistry 41: 4193-4201.
27. Siomi, H., Matunis, M.J., Michael, W.M., and Dreyfuss, G. 1993. The pre-mRNA binding K protein contains a novel evolutionarily conserved motif. Nucleic Acids Res. 21: 1193-1198.
28. Siomi, H., Choi, M.C., Siomi, M.C., Nussbaum, R.L., and Dreyfuss, G. 1994. Essential role for KH domains in RNA binding: Impaired RNA binding by a mutation in the KH domain of Fmr1 that causes fragile X syndrome. Cell 77: 33-39.
29. 15N, 13C-labeled RNA oligonucleotides. J. Biomol. NMR 3: 721-727.
30. Tamanini, F., Bontekoe, C., Bakker, C.E., van Unen, L., Anar, B., Willemsen, R., Yoshida, M., Galjaard, H., Oostra, B.A., and Hoogeveen, A.T. 1999. Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations. Hum. Mol. Genet. 8: 863-869.
31. Thompson, J.D., Gibson, T.J., Plewniak, F., Jeanmougin, F., and Higgins, D.G. 1997. The CLUSTALX windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25: 4876-4882.
32. Varani, G., Aboul-ela, F., and Allain, H.T. 1996. NMR investigation of RNA structure. Progr. Nucl. Magn. Res. 29: 51-127.
33. Worbs, M., Bourenkov, G.P., Bartunik, H.D., Huber, R., and Wahl, M.C. 2001. An extended RNA binding surface through arrayed S1 and KH domains in transcription factor NusA. Mol. Cell 7: 1177-1189.